LeMaitre Historical Income Statement

LMAT Stock

USD 106.99 1.19 1.12%

Historical analysis of LeMaitre Vascular income statement accounts such as Other Operating Expenses of 164.2 M can show how well LeMaitre Vascular performed in making a profits. Evaluating LeMaitre Vascular income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of LeMaitre Vascular's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining LeMaitre Vascular latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether LeMaitre Vascular is a good buy for the upcoming year.

Net Income Gross Profit

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.

About LeMaitre Income Statement Analysis

LeMaitre Vascular Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to LeMaitre Vascular shareholders. The income statement also shows LeMaitre investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

LeMaitre Vascular Income Statement Chart

At this time, LeMaitre Vascular's Income Before Tax is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 2.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 18.8 M in 2024.

Gross Profit Other Operating Expenses Research Development

Gross Profit

Gross profit is a required income statement account that reflects total revenue of LeMaitre Vascular minus its cost of goods sold. It is profit before LeMaitre Vascular operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of LeMaitre Vascular. It is also known as LeMaitre Vascular overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from LeMaitre Vascular's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into LeMaitre Vascular current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in LeMaitre Vascular. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

For more information on how to buy LeMaitre Stock please use our How to Invest in LeMaitre Vascular guide.At this time, LeMaitre Vascular's Income Before Tax is comparatively stable compared to the past year. Total Other Income Expense Net is likely to gain to about 2.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 18.8 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	101.4M	104.9M	127.0M	133.4M
Total Revenue	154.4M	161.7M	193.5M	203.2M

Gross Profit Total Revenue

LeMaitre Vascular income statement Correlations

	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Interest Expense		0.21	0.21	0.19	0.07	0.18	0.18	0.2	0.21	0.29	0.22	0.33	0.25	0.08	0.26	0.26	0.27	0.35	-0.15	0.24	0.01	-0.01	-0.17	0.27	0.17
Total Revenue	0.21		1.0	1.0	0.93	0.95	0.99	0.96	1.0	0.82	0.96	0.26	0.95	0.96	0.96	0.78	0.82	0.82	0.47	0.77	0.84	0.8	0.44	0.83	-0.66
Gross Profit	0.21	1.0		1.0	0.94	0.94	0.98	0.95	0.99	0.83	0.96	0.29	0.95	0.96	0.95	0.76	0.83	0.82	0.44	0.76	0.83	0.8	0.44	0.81	-0.66
Other Operating Expenses	0.19	1.0	1.0		0.91	0.93	0.99	0.94	0.99	0.82	0.94	0.27	0.92	0.95	0.95	0.76	0.82	0.78	0.48	0.78	0.82	0.83	0.48	0.81	-0.69
Operating Income	0.07	0.93	0.94	0.91		0.88	0.91	0.88	0.91	0.72	0.98	0.43	0.97	0.95	0.84	0.7	0.77	0.85	0.33	0.72	0.81	0.79	0.47	0.67	-0.67
Ebit	0.18	0.95	0.94	0.93	0.88		0.92	1.0	0.95	0.73	0.93	0.04	0.92	0.93	0.95	0.8	0.72	0.81	0.5	0.66	0.86	0.71	0.28	0.88	-0.63
Research Development	0.18	0.99	0.98	0.99	0.91	0.92		0.94	0.99	0.79	0.93	0.28	0.92	0.94	0.95	0.77	0.8	0.77	0.54	0.8	0.84	0.86	0.51	0.82	-0.72
Ebitda	0.2	0.96	0.95	0.94	0.88	1.0	0.94		0.97	0.75	0.94	0.06	0.92	0.94	0.97	0.81	0.73	0.82	0.5	0.67	0.87	0.71	0.27	0.89	-0.62
Cost Of Revenue	0.21	1.0	0.99	0.99	0.91	0.95	0.99	0.97		0.8	0.95	0.22	0.93	0.95	0.98	0.81	0.8	0.81	0.52	0.78	0.85	0.81	0.42	0.87	-0.67
Total Operating Expenses	0.29	0.82	0.83	0.82	0.72	0.73	0.79	0.75	0.8		0.77	0.25	0.77	0.76	0.79	0.81	0.95	0.83	0.23	0.57	0.78	0.53	0.25	0.71	-0.22
Income Before Tax	0.22	0.96	0.96	0.94	0.98	0.93	0.93	0.94	0.95	0.77		0.36	1.0	0.96	0.92	0.78	0.78	0.91	0.35	0.71	0.85	0.74	0.35	0.79	-0.6
Total Other Income Expense Net	0.33	0.26	0.29	0.27	0.43	0.04	0.28	0.06	0.22	0.25	0.36		0.39	0.24	0.11	0.14	0.42	0.37	-0.19	0.51	0.08	0.42	0.53	-0.09	-0.22
Net Income	0.25	0.95	0.95	0.92	0.97	0.92	0.92	0.92	0.93	0.77	1.0	0.39		0.94	0.91	0.78	0.77	0.92	0.33	0.71	0.83	0.73	0.33	0.78	-0.58
Income Tax Expense	0.08	0.96	0.96	0.95	0.95	0.93	0.94	0.94	0.95	0.76	0.96	0.24	0.94		0.92	0.75	0.77	0.82	0.41	0.69	0.89	0.76	0.39	0.79	-0.65
Depreciation And Amortization	0.26	0.96	0.95	0.95	0.84	0.95	0.95	0.97	0.98	0.79	0.92	0.11	0.91	0.92		0.85	0.74	0.83	0.51	0.69	0.87	0.69	0.25	0.94	-0.55
Selling General Administrative	0.26	0.78	0.76	0.76	0.7	0.8	0.77	0.81	0.81	0.81	0.78	0.14	0.78	0.75	0.85		0.8	0.85	0.51	0.68	0.88	0.59	0.22	0.88	-0.29
Selling And Marketing Expenses	0.27	0.82	0.83	0.82	0.77	0.72	0.8	0.73	0.8	0.95	0.78	0.42	0.77	0.77	0.74	0.8		0.8	0.28	0.72	0.77	0.68	0.49	0.62	-0.36
Net Income From Continuing Ops	0.35	0.82	0.82	0.78	0.85	0.81	0.77	0.82	0.81	0.83	0.91	0.37	0.92	0.82	0.83	0.85	0.8		0.18	0.56	0.82	0.5	0.1	0.76	-0.25
Non Recurring	-0.15	0.47	0.44	0.48	0.33	0.5	0.54	0.5	0.52	0.23	0.35	-0.19	0.33	0.41	0.51	0.51	0.28	0.18		0.6	0.55	0.61	0.38	0.63	-0.58
Non Operating Income Net Other	0.24	0.77	0.76	0.78	0.72	0.66	0.8	0.67	0.78	0.57	0.71	0.51	0.71	0.69	0.69	0.68	0.72	0.56	0.6		0.6	0.89	0.76	0.57	-0.68
Tax Provision	0.01	0.84	0.83	0.82	0.81	0.86	0.84	0.87	0.85	0.78	0.85	0.08	0.83	0.89	0.87	0.88	0.77	0.82	0.55	0.6		0.65	0.24	0.87	-0.46
Interest Income	-0.01	0.8	0.8	0.83	0.79	0.71	0.86	0.71	0.81	0.53	0.74	0.42	0.73	0.76	0.69	0.59	0.68	0.5	0.61	0.89	0.65		0.83	0.55	-0.9
Net Interest Income	-0.17	0.44	0.44	0.48	0.47	0.28	0.51	0.27	0.42	0.25	0.35	0.53	0.33	0.39	0.25	0.22	0.49	0.1	0.38	0.76	0.24	0.83		0.05	-0.74
Reconciled Depreciation	0.27	0.83	0.81	0.81	0.67	0.88	0.82	0.89	0.87	0.71	0.79	-0.09	0.78	0.79	0.94	0.88	0.62	0.76	0.63	0.57	0.87	0.55	0.05		-0.4
Extraordinary Items	0.17	-0.66	-0.66	-0.69	-0.67	-0.63	-0.72	-0.62	-0.67	-0.22	-0.6	-0.22	-0.58	-0.65	-0.55	-0.29	-0.36	-0.25	-0.58	-0.68	-0.46	-0.9	-0.74	-0.4

Click cells to compare fundamentals

LeMaitre Vascular Account Relationship Matchups

LeMaitre Vascular income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Interest Expense	21K	2K	5.9M	1.3M	2.2M	986K
Total Revenue	117.2M	129.4M	154.4M	161.7M	193.5M	203.2M
Gross Profit	79.9M	84.6M	101.4M	104.9M	127.0M	133.4M
Other Operating Expenses	96.0M	101.0M	118.0M	131.7M	156.4M	164.2M
Operating Income	15.8M	19.8M	25.6M	21.2M	37.1M	38.9M
Ebit	15.8M	28.7M	36.5M	27.5M	39.5M	41.4M
Research Development	9.3M	10.1M	11.8M	13.3M	17.0M	17.8M
Ebitda	21.2M	36.9M	46.0M	36.9M	49.0M	51.4M
Cost Of Revenue	37.4M	44.7M	53.0M	56.8M	66.4M	69.8M
Total Operating Expenses	58.7M	56.3M	65.0M	75.0M	90.3M	45.5M
Income Before Tax	21.7M	27.4M	34.3M	27.5M	39.5M	41.4M
Total Other Income Expense Net	5.9M	(1.4M)	(2.1M)	661K	2.4M	2.5M
Net Income	17.9M	21.2M	26.9M	20.6M	30.1M	31.6M
Income Tax Expense	3.7M	6.1M	7.4M	6.9M	9.4M	9.8M
Depreciation And Amortization	5.4M	8.2M	9.5M	9.4M	9.5M	10.0M
Selling General Administrative	19.1M	22.5M	25.5M	28.7M	31.8M	18.8M
Net Income Applicable To Common Shares	17.9M	21.2M	26.9M	20.6M	23.7M	24.9M
Selling And Marketing Expenses	30.3M	23.7M	27.7M	32.9M	41.1M	26.5M
Net Income From Continuing Ops	17.9M	21.2M	26.9M	20.6M	27.3M	15.6M
Non Operating Income Net Other	496K	(122K)	81K	661K	760.2K	798.2K
Tax Provision	3.7M	6.1M	7.4M	6.9M	8.7M	6.3M
Interest Income	698K	207K	197K	986K	2.5M	2.7M
Net Interest Income	698K	(1.3M)	(2.0M)	986K	2.5M	2.7M
Reconciled Depreciation	5.4M	8.4M	11.1M	9.4M	9.4M	8.2M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for LeMaitre Stock Analysis

When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

LeMaitre Historical Income Statement

About LeMaitre Income Statement Analysis

LeMaitre Vascular Income Statement Chart

Gross Profit

Other Operating Expenses

LeMaitre Vascular income statement Correlations

LeMaitre Vascular Account Relationship Matchups

High Positive Relationship

High Negative Relationship

LeMaitre Vascular income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for LeMaitre Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Gross Profit	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Other Operating Expenses	+ 1.0	Gross Profit
Ebitda	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax

Extraordinary Items	- 0.9	Interest Income
Extraordinary Items	- 0.74	Net Interest Income
Extraordinary Items	- 0.72	Research Development
Extraordinary Items	- 0.69	Other Operating Expenses
Extraordinary Items	- 0.68	Non Operating Income Net Other
Extraordinary Items	- 0.67	Cost Of Revenue